Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Nicotine Transdermal Patch

Known as: Nicotine patch, Transdermal Patch, Nicotine, Patch, Nicotine Transdermal 
A transdermal patch containing the alkaloid nicotine with nicotine replacement activity. Upon administration of the patch, nicotine is slowly… Expand
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

24 HR Nicotine 0.292 MG/HR Transdermal System24 HR Nicotine 0.875 MG/HR Transdermal System

Broader (2)

Nicotinenicotine replacement

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Quit Methods Used by US Adult Cigarette Smokers, 2014–2016
To quantify the prevalence of 10 quit methods commonly used by adult cigarette smokers, we used data from a nationally… Expand
  • table 1
  • table 2
Is this relevant?
Highly Cited
2016
Highly Cited
2016
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical…
BACKGROUND Substantial concerns have been raised about the neuropsychiatric safety of the smoking cessation medications… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Electronic cigarettes for smoking cessation: a randomised controlled trial
BACKGROUND Electronic cigarettes (e-cigarettes) can deliver nicotine and mitigate tobacco withdrawal and are used by many smokers… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial
BACKGROUND Varenicline, a new treatment for smoking cessation, has demonstrated significantly greater efficacy over placebo and… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Review
2008
Review
2008
Sex differences in long-term smoking cessation rates due to nicotine patch.
Compared to men, women may be at greater risk for smoking-related diseases and have greater difficulty quitting smoking. Sex… Expand
  • table 1
  • figure 1
Is this relevant?
Review
2004
Review
2004
Current status and future potential of transdermal drug delivery
The past twenty five years have seen an explosion in the creation and discovery of new medicinal agents. Related innovations in… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Nicotine replacement therapy in smoking cessation.
Evidence for benefit from nicotine replacement therapy in hospital patients is inconclusive, although the results of a trial… Expand
  • table 1
Is this relevant?
Highly Cited
1999
Highly Cited
1999
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
BACKGROUND AND METHODS Use of nicotine-replacement therapies and the antidepressant bupropion helps people stop smoking. We… Expand
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Modulation of oxidant stress in vivo in chronic cigarette smokers.
BACKGROUND Free radical-induced oxidative damage is thought to be involved in the pathogenesis of diseases associated with… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Predicting smoking cessation. Who will quit with and without the nicotine patch.
OBJECTIVE To identify predictors of smoking cessation success or failure with and without transdermal nicotine patch treatment… Expand
  • table 1
  • table 2
  • table 5
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE